Related Experiment Video
Updated: Feb 25, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
Inhibition of microRNA-214-5p promotes cell survival and extracellular matrix formation by targeting collagen type IV
1Department of Traumatology, Eastern Medical District of Linyi People's Hospital, Linyi, China.
Objectives:
This study aimed to investigate the functional effects of microRNA (miR)-214-5p on osteoblastic cells, which might provide a potential role of miR-214-5p in bone fracture healing.
Methods:
Blood samples were obtained from patients with hand fracture or intra-articular calcaneal fracture and from healthy controls (HCs). Expression of miR-214-5p was monitored by qRT-PCR at day 7, 14 and 21 post-surgery. Mouse osteoblastic MC3T3-E1 cells were transfected with antisense oligonucleotides (ASO)-miR-214-5p, collagen type IV alpha 1 (COL4A1) vector or their controls; thereafter, cell viability, apoptotic rate, and the expression of collagen type I alpha 1 (COL1A1), type II collagen (COL-II), and type X collagen (COL-X) were determined. Luciferase reporter assay, qRT-PCR, and Western blot were performed to ascertain whether COL4A1 was a target of miR-214-5p.
Results:
Plasma miR-214-5p was highly expressed in patients with bone fracture compared with HCs after fracture (p < 0.05 or p < 0.01). Inhibition of miR-214-5p increased the viability of MC3T3-E1 cells and the expressions of COL1A1 and COL-X, but decreased the apoptotic rate and COL-II expression (p < 0.05 or p < 0.01). COL4A1 was a target of miR-214-5p, and was negatively regulated by miR-214-5p (p < 0.05 or p < 0.01). Overexpression of COL4A1 showed a similar impact on cell viability, apoptotic rate, and COL1A1, COL-II, and COL-X expressions inhibiting miR-214-5p (p < 0.01).
Conclusion:
Inhibition of miR-214-5p promotes cell survival and extracellular matrix (ECM) formation of osteoblastic MC3T3-E1 cells by targeting COL4A1.Cite this article: Q. S. Li, F. Y. Meng, Y. H. Zhao, C. L. Jin, J. Tian, X. J. Yi. Inhibition of microRNA-214-5p promotes cell survival and extracellular matrix formation by targeting collagen type IV alpha 1 in osteoblastic MC3T3-E1 cells. Bone Joint Res 2017;6:464-471. DOI: 10.1302/2046-3758.68.BJR-2016-0208.R2.
Insights
Inhibition of microRNA-214-5p (miR-214-5p) enhances osteoblastic cell survival and extracellular matrix formation by targeting collagen type IV alpha 1 (COL4A1). This finding offers potential therapeutic strategies for bone fracture healing.
Area of Science:
- Biochemistry
- Molecular Biology
- Orthopedics
Background:
- MicroRNAs (miRNAs) play crucial roles in cellular processes, including bone metabolism.
- Dysregulation of specific miRNAs has been implicated in bone fracture healing.
- miR-214-5p's role in osteoblastic cells and bone healing requires further elucidation.
Purpose of the Study:
- To investigate the functional impact of miR-214-5p on osteoblastic cells.
- To explore the potential of miR-214-5p as a therapeutic target for bone fracture healing.
Main Methods:
- Quantification of plasma miR-214-5p expression in fracture patients versus healthy controls using qRT-PCR.
- In vitro studies using MC3T3-E1 cells transfected with miR-214-5p inhibitors or COL4A1 vectors.
- Assessment of cell viability, apoptosis, and expression of collagen genes (COL1A1, COL-II, COL-X).
- Luciferase reporter assays, qRT-PCR, and Western blot to confirm COL4A1 as a direct target of miR-214-5p.
Main Results:
- Plasma miR-214-5p levels were significantly elevated in bone fracture patients.
- Inhibition of miR-214-5p promoted MC3T3-E1 cell viability and expression of COL1A1 and COL-X, while reducing COL-II expression and apoptosis.
- COL4A1 was identified as a direct target of miR-214-5p, negatively regulated by it.
- Overexpression of COL4A1 mimicked the effects of miR-214-5p inhibition on cell behavior and gene expression.
Conclusions:
- Inhibition of miR-214-5p enhances osteoblastic cell survival and extracellular matrix formation.
- The mechanism involves the targeting of COL4A1 by miR-214-5p.
- miR-214-5p inhibition represents a promising therapeutic avenue for improving bone fracture healing.
More Related Videos
06:00Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines
Published on: September 13, 2017
09:45An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
Related Concept Videos
MicroRNAs
MicroRNAs
Abnormal Proliferation